Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Regulatory News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.45
Bid: 12.20
Ask: 12.70
Change: 0.15 (1.22%)
Spread: 0.50 (4.098%)
Open: 12.30
High: 12.45
Low: 12.45
Prev. Close: 12.30
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Date   Source Headline
9th May 20247:00 amRNSAnnual Report & AGM Notice
1st May 20247:00 amRNSSignificant POLB 001 Patent Granted in USA
30th Apr 20247:02 amRNSAppointment of Joint Broker
30th Apr 20247:01 amRNSOption Agreement to Acquire Orphan Drug Candidate
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
29th Apr 20247:00 amRNSTR-1: Notification of major holdings
22nd Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 20241:42 pmRNSDirector Share Purchase
15th Feb 20247:00 amRNSBoard Role Change and Launch of EIP
17th Jan 20247:00 amRNSFurther data shows POLB001 potential in cancer CRS
20th Dec 20237:00 amRNSRSV AI Drug Candidate Analysis Update
11th Dec 20237:00 amRNSPOLB 001 Data Presented at ASH
30th Nov 20237:00 amRNSDirectorate Change
21st Nov 20237:00 amRNSImmunomodulator II patent granted in Japan
16th Nov 20237:00 amRNSPOLB 001 LPS Trial Data to be Presented at IUIS
9th Nov 20237:00 amRNSFormer Amryt Pharma Leadership Team join Poolbeg
3rd Nov 20237:05 amRNSPOLB001 Data to be Presented at ASH Annual Meeting
1st Nov 20237:00 amRNSPOLB 001 Oncology Programme Update Meeting
26th Oct 20237:00 amRNSSAB Endorses Influenza Drug Targets
17th Oct 20237:00 amRNSPoolbeg Partners with a Nasdaq-Listed Biopharma
29th Sep 20237:00 amRNSFavourable Conclusion of Patent Opposition
20th Sep 20237:00 amRNSImmunomodulator I Patent Portfolio Strengthened
19th Sep 20237:00 amRNSImmunomodulator I Patent Opposition Withdrawal
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
29th Jun 20237:00 amRNSAI led programme identifies influenza drug targets
22nd Jun 20237:00 amRNSOral Vaccine Programme Moves Forward
24th May 20237:00 amRNSBoard Appointment
11th May 20232:27 pmRNSResults of Annual General Meeting
12th Apr 20237:00 amRNSAnnual Report & AGM Notice
30th Mar 20237:00 amRNSResults for the year ended 31 December 2022
10th Mar 20237:00 amRNSNotification of Major Holdings
9th Mar 20233:51 pmRNSNotification of Major Holdings
8th Mar 20237:00 amRNSPOLB 001 patent portfolio strengthened
2nd Mar 202311:05 amRNSSecond Price Monitoring Extn
2nd Mar 202311:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSPositive Results POLB001 LPS Human Challenge Trial
16th Jan 20237:00 amRNSStrategic expansion of POLB 001 into oncology
9th Jan 20239:05 amRNSSecond Price Monitoring Extn
9th Jan 20239:00 amRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSPositive Initial Data Analysis in POLB 001 Trial
22nd Dec 202210:48 amEQSPoolbeg Pharma identifies new RSV drug candidates
21st Dec 20227:00 amRNSPoolbeg identifies novel RSV drug candidates
15th Dec 20229:49 amEQSPoolbeg Pharma makes 'interesting addition to existing collaboration'
14th Dec 20227:00 amRNSMetabolic diseases oral delivery licence signed
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202212:00 pmEQSPoolbeg Pharma receives initial results from human challenge clinical study
12th Dec 20227:00 amRNSPOLB 001 LPS human challenge trial completed
29th Nov 20227:00 amRNSInfluenza AI model build completed
21st Nov 202211:37 amEQSPoolbeg Pharma wins first non-dilutive grant funding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.